Medicus Sciences Acquisition Corp. Unit
MSACU
MSACU was delisted on the 6th of April, 2021.
40 hedge funds and large institutions have $80.5M invested in Medicus Sciences Acquisition Corp. Unit in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.03M |
| 2 |
HM
HealthCor Management
New York
|
+$8.03M |
| 3 |
TP
Third Point
New York
|
+$8.03M |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$6.1M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.29M |
Top Sellers
MSACU Hedge Fund Activity: Q1 2021 in Review
40 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Unit (MSACU) for Q1 2021, worth a combined $80.5M.
Buyers outnumbered sellers: 40 funds opened new MSACU positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $8.03M.
- 40 institutional investors held Medicus Sciences Acquisition Corp. Unit (MSACU) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $80.5M of Medicus Sciences Acquisition Corp. Unit stock for Q1 2021.
- 40 funds opened new Medicus Sciences Acquisition Corp. Unit positions in Q1 2021 and 0 closed out, a net change of +40 holders.
- The largest Medicus Sciences Acquisition Corp. Unit buyer in Q1 2021 was Adage Capital Partners, an estimated $8.03M added.
Based on aggregated 13F filings for Q1 2021.